All Wales Medicines Strategy Group Final Appraisal Report - Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate.

D. Hughes; D.A. Hughes; [No Value] All Wales Strategy Group.

All Wales Medicines Strategy Group Final Appraisal Report - Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate.

D. Hughes
, D.A. Hughes
, [No Value] All Wales Strategy Group.

NHS Wales

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Iaith wreiddiol	Saesneg
Cyhoeddwr	Unknown
Corff comisiynu	NHS Wales
Argraffiad	2008
Statws	Cyhoeddwyd - 1 Ion 2008

Ffeiliau eraill a chysylltiadau

http://www.wales.nhs.uk/sites3/Documents/371/Alemtuzumab%20(MabCampath)%20FAR.pdf

Dyfynnu hyn

@book{27f8c0fba610411f89ee320e4b40859b,

title = "All Wales Medicines Strategy Group Final Appraisal Report - Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate.",

author = "D. Hughes and D.A. Hughes and \{All Wales Strategy Group.\}, \{[No Value]\}",

year = "2008",

month = jan,

day = "1",

language = "English",

publisher = "Unknown",

edition = "2008",

}

TY - BOOK

T1 - All Wales Medicines Strategy Group Final Appraisal Report - Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate.

AU - Hughes, D.

AU - Hughes, D.A.

AU - All Wales Strategy Group., [No Value]

PY - 2008/1/1

Y1 - 2008/1/1

UR - http://www.wales.nhs.uk/sites3/Documents/371/Alemtuzumab%20(MabCampath)%20FAR.pdf

M3 - Commissioned report

BT - All Wales Medicines Strategy Group Final Appraisal Report - Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate.

PB - Unknown

ER -